In conclusion, GAS5 and miR-21 in CD4<sup>+</sup> T cells may serve as potential biomarkers for the diagnosis and monitoring of the progression of SLE.
In summary, the expression levels of linc0597, lnc-DC and GAS5 are decreased in SLE patients, but their gene polymorphisms are not associated with SLE risk, and do not influence their expression levels.